HCW Biologics — Valuation, Funding & Investors

Recent changes

Jul 29, 2026Jul 29, 2026Raised $1.6M SEC EDGAR Form D
Jun 8, 2026Jun 8, 2026HCW Biologics Files S-1 for Small $5.6M Best-Efforts Raise Pulse story

Funding History

1 event · sources dated per row

Date	Event	Amount	Valuation	Investors	Source
Jul 29, 2026	funding round	$1.6M	—		SEC EDGAR Form D

Latest Pulse

Jun 8, 2026HCW Biologics Files S-1 for Small $5.6M Best-Efforts RaiseHCW Biologics filed an S-1 for a best-efforts offering of up to $5.6 million, a modest raise reflecting the tighter capital-access conditions many small-cap clinical-stage biotechs still face despite the broader 2026 IPO boom.→

Coverage Timeline

newest first

Jun 8, 2026IPOHCW Biologics Files S-1 for Small $5.6M Best-Efforts Raise→

All Coverage

IPO· Jun 8, 2026

HCW Biologics Files S-1 for Small $5.6M Best-Efforts Raise

IPO

HCW Biologics Files S-1 for Small $5.6M Best-Efforts Raise

HCW Biologics filed an S-1 for a best-efforts offering of up to $5.6 million, a modest raise reflecting the tighter capital-access conditions many small-cap clinical-stage biotechs still face despite the broader 2026 IPO boom.

Jun 8, 2026

Related Companies

Same sector

Attovia Therapeutics Apnimed Braveheart Bio Latigo Biotherapeutics Scribe Therapeutics

Sources & methodologyshow

Where these figures come from

SEC EDGAR Form Dprimary source1 fact

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction